The effects of loading dose of procaine amide (Pr Am) 50 mg per minute IV for 10 minutes were assessed in 14 patients with heart disease. The mean (kSEM) of the values prior to (C) and at the end of Pr Am infusion (A) were: blood Pr Am A 42-c28 (SD) pg/ml, cardiac index (CI) C 2.6 (&0.187), A 2.3 ("0.17); mean aortic pressure (AO) C 93.5 (25.2), A 86 (k5.4); left ventricular end-diastolic pressure (LVEDP) C 17 (22.7), A 13 (k2.4); LV peak dp/dt C 1434 ( k 137), A 1205.4 ( k 105); left ventricular stroke work (LVSW) C 51 (*6.7), A 42 (26.2), mean pulmonary artery pressure (PA) C 31 0 ur clinical experience with procaine amide over many years showed relative safety of intravenous injection in the treatment of ventricular tachycardia even when a relatively large dose was administered at a faster rate than the r&mmended one. In this study procaine amide was given in a dose of 500 mg over a 10 minute period and it reached blood levels 5 to 10 times the usual therapeutic concentration in man. Although the parameters of cardiac functions were reduced at statistically significant level, there was no morbidity. The excessi;e dose was quite well tolerated. his-conclusion is clinically sign8cant as the drug is a very potent and useful antiahhythmic drug.
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Fourteen patients were studied (Table 1 ) . Their ages ranged from 19 to 70 years with an average of 46 years. Of these, seven had alcoholic cardiomyopathy, four mitral stenosis, one hypertensive heart, one mild aortic insufticiency, one traumatic injury to the myocardium. Patients with m i d insufficiency, moderate or severe aortic insufticiency, and an intracardiac shunt were excluded. An 6 SD) ]. There were no significant changes in heart rate and systemic arterial resistance. The data showed that the excessive dose of the drug was quite well tolerated and although parameters of cardiac function were reduced at statistically significant level at the zero time (end of procaine amide infusion) there was no morbidity.
put was determined by the dye indicator dilution technique according to the method of Hamilton and associates.1 Indocyanine green was injected into the pulmonary artery; the sampling site was the aorta. With the use of a Harvard infusion pump, blood was withdrawn at a constant rate of 15 to 30 ml per minute past a densitometer (Model D 400, Waters Corporation, Rochester, Minnesota), and the change in optical density associated with the passage of dye was amplified and recorded. Two dye curves were performed for each period of study and the mean value was used. The densitometer was calibrated using the patient's blood. Heart rate ( HR ) was determined from electrocardiogram. Stroke volume ( SV) was determined by dividing the cardiac output by the heart rate. Cardiac output and stroke volume were divided by the body surface in M2 to give the cardiac index ( C I ) and stroke index ( SI), respectively.
Left ventricular stroke work (LVSW) was calculated by The first derivative of the ventricular pressure pulse (dp/dt) was computed by means of an electronic differentiating circuit.
Systolic time intervals (STI) in milliseconds were determined from the phonocardiogram, ECG and aortic pressure pulse with the use of the method described by Weissler, Harris and Schoenfeld.2 QS2 is the time from the onset of the Q wave of the ECG to the first high frequency vibration of were recorded at 25 millimeters per second from which the heart rate, PR, QRS and QT intervals were measured. The Qt interval was corrected for heart rate to give the Qt, interval.
The blood level of procaine amide in pg/ml was determined at 0, 10 and 30 minutes after the conclusion of procaine amide infusion whenever possible. The method used was a modified spectrophotometric method of Mark and associates.s Procaine amide was extracted from alkalinized serum with chloroform and then reextracted into 1 N hydrochloric acid and diazolized. Aqueous procaine amide standards treated similarly were compared in spectrophotometer at 550 mu.
Procedure
The study was carried out half an hour after the last diagnostic angiocardiogram when all the parameters had returned to preangiocardiographic status. Procaine amide diluted with 15 ml physiologic saline was administered intravenously at a rate of 50 milligrams per minute for 10 minutes. Intracardiac and intravascular pressures, dp/dt, CO and ECG recordings were repeated at the end of procaine amide infusion (zero time) and 10, 20 and 30 minutes later. There was no morbidity or mortality.
The study took about one hour. It was difficult to obtain all the parameters at the decided intervals after procaine infusion. The comfort of the patient was the determining factor. Technical difficulties account for some of the missing parameters. The mean and standard error of the mean of the values obtained in the patients at the various times are shown in Table 2 .
Effect of Procaine Amide on Heart Rate, PR, QRS, and QT, Interuals
The heart rate showed slight variation. There was no change in the PR and QRS intervals. There was, however, a statistically significant increase in the QT, interval at 0 time.
Effect of Procaine Amide on Cardiac Index (CI) and Stroke Index (SI)
There was a statistically significant decrease in the CI at 0 and 10 minutes and in (SI) at 0 time.
Effect of Procaine Amide on Pressures
There was a statistically significant decrease in the mean aortic pressure at 0, 10,U) and 30 minutes. The left ventricular end-diastolic pressure (Fig 1) decreased at 0, 10, 20 and 30 minutes. The decrease was of no statistical significance at 30 minutes. The decrease in the mean pulmonary arterial pressure was of statistical significance at 0 and 10 minutes. The decrease in the right ventricular systolic and mean right atrial pressure (RA) was of no statistical significance.
Effect of Procaine on Left Ventricular Stroke Work (LVSW)
The decrease in LVSW at 0, 10, 20 and 30 minutes (Fig 1) was of statistical significance.
Effect of Procaine Amide on the Peak Rate of Intraventricular Pressure Rise (Peak DPI DT)
There was a statistically significant decrease in peak dp/dt at 0,10,20 and 30 minutes (Fig 2) .
Effect of Procaine Amide on Systolic T i m lnteroals
The data showed an increase in the PEPc at 0,10, 20 and 30 minutes (Fig 1 ) . The increase was of statistical significance at 10 minutes. The changes in LVET, and PEPILVET were insignificant. Abbreviations: LV =left ventricular systolic pressure; LVEDP =left ventricular end diastolic pressure; DP/DT =peak rate of intraventricular pressure rise during isovolumic systolic; LVSW=left ventricular stroke work; PA=mean pulmonary artery pressure; RV =right ventricular systolic pressure.
Efect of Procaine Amide on Systemic Vascular Resistance
The changes were of no statistical significance.
Concentration of Procaine Amide
The mean concentration at 0 times was 42 mg/L with SD of 228, at 10 minutes, 7 mg with SD of +-3 and at 30 minutes 4 mg with SD k2.6.
The changes in cardiac output, myocardial contractility and systemic blood pressure were found to be proportional to the dose as well as to speed of intravenous injection of procaine amide.46 In this study the effects of procaine amide intravenous injection in loading dose of 500 mg over 10 minutes on left ventricular function in man was assessed and correlated with drug blood level. The maximal effect of the drug was at the end of injection when the concentration was at its peak (42 mg/L). This is five to ten times the therapeutic concentration in
The flow and pressure data showed statistically significant decline in cardiac index, stroke index, mean aortic and left ventricular systolic pressures. As a result of diminished cardiac output and aortic systolic pressure, cardiac stroke work was reduced too. This was consistent with depression of cardiac pump performance. The peak rate of intraventricular pressure rise (peak dp/dt), was decreased too. This decline was compatible with negative inotropic effect of procaine amide. The prolongation of the PEPc and increased PEPJLVET is consistent with this reduced inot r~p y .~, l~
The shortening of the LVETc is in harmony with significantly diminished stroke volume since at any heart rate the principal factor influencing left ventricular peak dp/dt, and preejection period corrected for heart rate (PEP.) in control state and at various intervals after intravenous procaine amide idhion.
the left ventricular ejection time is stroke vol~rne.'~ The foregoing data are consistent with myocardial depressing effect of procaine amide. It is remarkable that, although parameters of cardiac function were reduced at a statistically significant level at the zero time (end of procaine arnide infusion), there was no morbidity. The excessive dose of the drug was quite well tolerated. Most of the hemodynamic effects waned after half an hour from the zero time, when the concentration of procaine amide was 4 mg/L, within the therapeutic (antiarrhythmic concentration) of procaine arnide.'s8
The persistence of some depression of function at 30 minutes was probably more related to the initial insult than to the therapeutic level of the drug at that time. The clinical relevance of the data is important as procaine amide is a very potent and useful antiarrhythmic agent. It is effective in at least 85 percent to 90 percent of ventricular arrhythmias." A good number of patients who did not respond to intravenous lidocaine would do so to intravenous procaine arnide. l2 Our study agrees with that of Bigger and coworkers12 that the unpopularity of intravenous procaine is unjustified. Thus even a loading dose intravenously did not produce morbidity. It is remarkable, too, that even the electrocardiographic effects of intravenous procaine amide at five to ten times the therapeutic concentration in man were clinically insignificant. Thus there were unremarkable effects on heart rate, atrioventricular (P-R) and ventricular conduction ( QRS ) intervals, although the qtc interval was prolonged sigdicantly (from the statistical point of view).
In conclusion, our study supports recent reports12*lS that procaine amide can be given intravenously with some margin of safety, since we exceeded by far the dose and, rate of administration that would be used clinically without morbidity. 
